CD79

CD79

CD79 is a protein complex that plays a crucial role in the immune system, specifically in the function of B cells. It is composed of two subunits, CD79a and CD79b, which are also known as Ig-alpha and Ig-beta, respectively. These subunits are integral components of the B cell receptor (BCR) complex, which is essential for B cell development, activation, and signaling.

Structure

The CD79 complex is a heterodimer consisting of the CD79a and CD79b proteins. Each subunit contains an extracellular immunoglobulin-like domain, a single transmembrane region, and a cytoplasmic tail. The cytoplasmic tails of CD79a and CD79b contain immunoreceptor tyrosine-based activation motifs (ITAMs), which are critical for signal transduction.

Function

CD79 is primarily involved in the initiation of B cell signaling. When an antigen binds to the B cell receptor, the CD79 complex transmits the signal across the cell membrane, leading to the activation of intracellular signaling pathways. This process involves the phosphorylation of the ITAMs by Src-family kinases, which then recruit and activate Syk kinase. The activation of these kinases triggers a cascade of downstream signaling events that result in B cell activation, proliferation, and differentiation.

Clinical Significance

Mutations or dysregulation of CD79 can lead to various immunological disorders. For example, defects in CD79a or CD79b can result in agammaglobulinemia, a condition characterized by an absence of immunoglobulins in the blood, leading to increased susceptibility to infections. Additionally, CD79 is a target for certain therapeutic interventions in B cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Research

Ongoing research is focused on understanding the precise mechanisms of CD79-mediated signaling and its role in B cell biology. Studies are also exploring the potential of targeting CD79 in the treatment of autoimmune diseases and B cell-related cancers.

Also see

• B cell receptor
• Immunoglobulin
• Signal transduction
• Agammaglobulinemia
• Chronic lymphocytic leukemia